Open AccessDecoding the Genetic Alteration in Genes of PARP Family and the Possible Association with HNSCC
Author(s) -
Harita Ravikumar,
Vijayashree Priyadharsini Jayaseelan,
A. S. Smiline Girija,
P. Sankar Ganesh,
Nidhi Poddar
Publication year - 2021
Publication title -
journal of pharmaceutical research international
Language(s) - English
Resource type - Journals
ISSN - 2456-9119
DOI - 10.9734/jpri/2021/v33i64a35692
Subject(s) - biology , gene , genetics , phenotype , dna repair , cancer research
Genetic alterations have long been associated with the transformation of normal cells into malignant cells. Several genes are related to exhibiting the phenotype. The PARP gene family is mainly involved in maintaining genome stability. They play an important role in DNA repair and the programmed cell death process.
Aim: To analyse the genetic alteration in PARP family and to determine its association with HNSCC.
Materials and Methods: Cbioportal was used as the primary database for identifying the mutations and variations. The data generated in the form of oncoprint was further assessed for frequency of occurrence, type and novelty.
Results and Discussion: It can be observed that greater amplification was found in the TIPARP gene which is 14% among all the 17 genes of the family. Also to add on, PARP 14 and PARP 15 show amplification patterns in similar groups of patients. Several types of mutations such as truncated, splicing deep deletion were found in most of the genes. The TIPARP gene was up-regulated in HNSCC patients. The Caucasians experiencing low/medium expression of TIPARP showed greater rates of survival than highly expressed African Americans. Similarly, males presenting with low or medium expression of TIPARP showed a greater rate of survival than the highly expressed females.
Conclusion: TIPARP could be a promising prognostic marker for screening populations vulnerable to acquiring HNSCC.